Non-surgical Local Treatments for Squamous Cell Carcinoma of the Skin

Cryotherapy, photodynamic therapy, topical chemotherapy, or other local treatments might be options to treat some squamous cell skin precancers or small squamous cell carcinomas (SCCs) that are at low risk for coming back, especially in people who can’t have or don’t want surgery.

These are called local treatments because they only affect the area being treated. Radiation therapy, another type of local treatment, is discussed separately.

Cryotherapy (cryosurgery)

Cryotherapy is the use of extreme cold to destroy tumors. It is used most often for skin precancers called actinic keratoses. It might also be an option for:

  • Squamous cell carcinoma in situ, also called Bowen disease (very early squamous cell skin cancer)
  • Small, well-defined squamous cell cancers that are at low risk for coming back

For this treatment, the doctor applies liquid nitrogen to the tumor to freeze and kill the cells. This is often repeated a couple of times in the same office visit.

Possible side effects

After the dead area of skin thaws, it will swell, blister, and crust over. The treated area might have fluid draining from it for a while, and it might take a month or two to heal. It will leave a scar, and the area might have less color after treatment.

Photodynamic therapy (PDT)

PDT can be used to treat skin precancers called actinic keratoses. It might also be an option to treat some very early forms of squamous cell cancer, known as squamous cell carcinoma in situ, or Bowen disease.

For this treatment, a drug is applied to the skin as a gel or liquid. The drug collects in the tumor cells over several hours, where it is converted to a different chemical that makes the cells very sensitive to certain types of light. A special light source is then focused on the tumor, which kills the cells.

When large areas need to be treated, daylight PDT, where the person goes out into the sunlight for a specific amount of time, might be an option.

Possible side effects

PDT can cause redness and swelling on the skin where it is used. PDT might also make a person’s skin very sensitive to sunlight for some time, so precautions might be needed to avoid severe burns.

Topical chemotherapy

Topical chemotherapy (chemo) means that an anti-cancer medicine is put directly on the skin, usually in a cream or ointment, rather than being taken by mouth or given into a vein (IV).

This is the drug most often used in topical treatment of actinic keratoses, as well as some early squamous cell skin cancers, with brand names such as Efudex, Carac, and Fluoroplex. It is typically applied to the skin once or twice a day for several weeks.

Sometimes 5-FU might be used along with calcipotriene, a drug related to vitamin D, which could shorten the length of treatment to days instead of weeks.

When put directly on the skin, 5-FU kills cancer cells on or near the skin’s surface, but it can’t reach cells deeper in the skin or those that have spread to other parts of the body. For this reason, topical 5-FU is generally used only for precancerous conditions.

Possible side effects

5-FU makes the treated skin red and very sensitive for a few weeks. Other topical medicines can be used to help relieve this, if needed. 5-FU can also make the skin more sensitive to sunlight, so treated areas should be protected from the sun to prevent sunburn for a few weeks after treatment.

A very small number of people have a condition called DPD deficiency, which makes it hard for their bodies to break down and get rid of 5-FU. This can result in serious or even life-threatening side effects. If you are applying 5-FU and have any reactions beyond those you were told to expect on your skin, call your doctor or nurse right away.

This chemo drug comes in an ointment that can be used to treat actinic keratoses on the face or scalp. It is usually applied to the skin once a day for 5 days. It’s important to avoid getting this drug in or near your eyes or mouth.

Possible side effects

The most common side effects of this drug include itching or pain in the treatment area. Some people might have more serious skin reactions, such as severe redness or swelling in the area, flaking, scaling, peeling, or crusting of the skin, blisters, pus, sores, or breakdown of the skin.

A gel containing the drug diclofenac is sometimes used to treat actinic keratoses. This drug is part of a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs), which includes aspirin and ibuprofen. The gel is usually applied twice daily for 2 or 3 months. It might cause less severe skin reactions than the chemo drugs above, but it can also take longer to work.

Imiquimod

Imiquimod (Zyclara) is a cream that can be applied to actinic keratoses. It causes the immune system to react to the skin lesion and destroy it. It’s typically applied at least a few times a week for several weeks, although schedules can vary.

Possible side effects

This drug irritates the skin, which might lead to itching, burning, redness, swelling, scabbing, crusting, or pain in the area. It can also make the skin more sensitive to sunlight, so treated areas should be protected from the sun to prevent sunburn for a few weeks after treatment. This drug can also cause flu-like symptoms in some people. The skin in the area being treated might also lose its pigment and become lighter in color.

Laser therapy (laser resurfacing)

This approach uses a beam of laser light to destroy the top layers of the skin. It might be an option for actinic keratosis or squamous cell carcinoma in situ (Bowen disease). It’s not yet known whether this type of treatment is as effective as standard methods of treatment, and it’s not widely used.

Chemical peeling

For this treatment, the doctor applies a chemical such as trichloroacetic acid (TCA) to the skin tumor, killing the tumor cells. This can lead to redness and peeling of the skin over the course of several days. This approach is sometimes used to treat actinic keratosis.

side by side logos for American Cancer Society and American Society of Clinical Oncology

Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).

Aasi SZ, Hong AM. Treatment and prognosis of low-risk cutaneous squamous cell carcinoma (cSCC). UpToDate. 2026. Accessed at https://www.uptodate.com/contents/treatment-and-prognosis-of-low-risk-cutaneous-squamous-cell-carcinoma-cscc on July 2, 2026.

Berman B. Treatment of actinic keratosis. UpToDate. 2026. Accessed at https://www.uptodate.com/contents/treatment-of-actinic-keratosis on July 2, 2026.

Maytin EV, Warren CB. Photodynamic therapy. UpToDate. 2026. Accessed at https://www.uptodate.com/contents/photodynamic-therapy on July 2, 2026.

National Cancer Institute. Skin Cancer Treatment (PDQ®)–Health Professional Version. 2025. Accessed at https://www.cancer.gov/types/skin/hp/skin-treatment-pdq on July 2, 2026.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Squamous Cell Skin Cancer. Version 2.2026. Accessed at https://www.nccn.org on July 2, 2026.

Wysong A. Squamous-cell carcinoma of the skin. N Engl J Med. 2023;388:2262-2273.

Xu YG, Aylward JL, Swanson AM, et al. Chapter 67: Nonmelanoma Skin Cancers. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020.

Last Revised: August 27, 2026

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.